Nurix Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold NRIX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$572010026
Total value held
Buying
16 added/new · 8 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $212768666 | 8770349 | -155293 | -1.74% |
| 2 | Morgan Stanley | $115537879 | 4762484 | -169515 | -3.44% |
| 3 | State Street Corp | $113469939 | 4677244 | -463951 | -9.02% |
| 4 | Ubs Group Ag | $22249259 | 917117 | +917117 | NEW BUY |
| 5 | Northern Trust Corp | $21253458 | 876070 | +21604 | +2.53% |
| 6 | Bank Of America Corp /De/ | $20429079 | 842089 | +39936 | +4.98% |
| 7 | Goldman Sachs Group Inc | $19737670 | 813589 | -505070 | -38.30% |
| 8 | Raymond James Financial Inc | $14392512 | 593262 | +239529 | +67.71% |
| 9 | Citigroup Inc | $9446456 | 389384 | +218282 | +127.57% |
| 10 | Bank Of New York Mellon Corp | $6614239 | 272640 | -22705 | -7.69% |
| 11 | Invesco Ltd. | $4319469 | 178049 | +178049 | NEW BUY |
| 12 | Prudential Financial Inc | $3521824 | 145170 | +100970 | +228.44% |
| 13 | Sei Investments Co | $2608193 | 107510 | +25402 | +30.94% |
| 14 | Wells Fargo & Company/Mn | $2512681 | 103573 | +47436 | +84.50% |
| 15 | Jpmorgan Chase & Co | $1161304 | 48692 | -1665 | -3.31% |
| 16 | Janus Henderson Group Plc | $610109 | 39400 | +39400 | NEW BUY |
| 17 | Barclays Plc | $545413 | 22482 | -1698 | -7.02% |
| 18 | Marex Group Ltd | $339640 | 14000 | +14000 | NEW BUY |
| 19 | Royal Bank Of Canada | $236000 | 9733 | +6046 | +163.98% |
| 20 | M&T Bank Corp | $226297 | 9328 | +9328 | NEW BUY |
| 21 | Pnc Financial Services Group, Inc. | $14556 | 600 | +150 | +33.33% |
| 22 | Us Bancorp \De\ | $10019 | 413 | +164 | +65.86% |
| 23 | Fifth Third Bancorp | $5294 | 218 | -30 | -12.10% |
| 24 | Amalgamated Financial Corp. | $70 | 4981 | +4981 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.